[3] Other common adverse effects reported during the clinical trials include back pain, upper respiratory tract infections, melanocyte naevus, decreased appetite, migraine, dizziness, weakness, fatigue, lethargy, sleepiness, hot flashes, abdominal pain, diarrhea, vomiting, flushing, development of warts, spots, and freckles, and itchy skin (between 1% and 10% of people)
GLP-1 receptor agonists represent a major shift away from traditional mechanical devices
The formation of new blood vessels at injury sites
Enforcement has been real
AM: Interesting
Adding 2ml creates 1mg/ml (1000mcg/ml)